| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 29 |
| 1 | INFLIXIMAB | 27 |
| 2 | INFLIXIMAB-DYYB | 25 |
| 3 | PREDNISONE | 18 |
| 4 | ACETAMINOPHEN | 13 |
| 5 | VEDOLIZUMAB | 13 |
| 6 | USTEKINUMAB | 10 |
| 7 | CIPROFLOXACIN | 9 |
| 8 | CIPROFLOXACIN HYDROCHLORIDE | 9 |
| 9 | METHOTREXATE SODIUM | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 25 | 0.0073 |
| 1 | ANORECTAL OINTMENT | 1 | 0.0046 |
| 2 | HYDROCORTISONE SODIUM SUCCINATE | 3 | 0.0008 |
| 3 | CLINDAMYCIN PHOSPHATE | 4 | 0.0007 |
| 4 | PRAZOSIN HYDROCHLORIDE | 1 | 0.0007 |
| 5 | TIVOZANIB | 1 | 0.0006 |
| 6 | CABAZITAXEL | 2 | 0.0006 |
| 7 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 1 | 0.0004 |
| 8 | PONATINIB HYDROCHLORIDE | 2 | 0.0004 |
| 9 | RIPRETINIB | 2 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Integrin Receptor Antagonist [EPC] | 13 | 0.0001 |
| 3 | Nitroimidazole Antimicrobial [EPC] | 9 | 0.0001 |
| 4 | Glinide [EPC] | 1 | 0.0001 |
| 5 | Interleukin-12 Antagonist [EPC] | 10 | 0.0001 |
| 6 | Interleukin-23 Antagonist [EPC] | 10 | 0.0001 |
| 7 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 8 | Purine Antimetabolite [EPC] | 8 | 0.0001 |
| 9 | Fluoroquinolone Antibacterial [EPC] | 8 | 0.0001 |